chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hair loss; migraine; Nausea; Fatigue; increase weight gain; no appetite; shooting pain in the muscles; Insomnia for 9 days; This is a spontaneous report from a contactable nurse. A 57-year-old female nurse (patient) reported for herself.  A 57-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0183, Expiration date: Unknown), via intramuscular route, administered in left arm (deltoid) on 20May2021 16:00 (at the age of 57-years-old) as dose 2, single for covid-19 immunisation in public health clinic/veterans administration facility. Medical history included known allergies. The concomitant medications were none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EW0179, Expiration date: Unknown), via intramuscular route, administered in deltoid on 29Apr2021 (at the age of 57-years-old) as dose 1, single for covid-19 immunisation and no problem with first injection. On 20May2021 at 02:00 Am, the patient experienced insomnia for 9 days. On 21May2021 at 02:00, the patient experienced, hair loss, migraine, nausea For 4 weeks, fatigue, increase weight gain, no appetite, shooting pain in the muscles. Since the vaccination, the patient has not been tested for COVID-19. Therapeutic measures were taken as a result of insomnia for 9 days, migraine with smudging with SAGE disease and Tylenol 500 mg respectively. The event Insomnia and nausea were reported as Persistent/ Significant disability/ Incapacity, Important medical event, migraine was reported as Persistent/ Significant disability/ Incapacity, and hair loss was reported as Important medical event. The outcome of the event migraine was resolved on an unspecified date in 2021 and nausea was resolved on 15Jun2021, hair loss was not resolved and other events were resolving.  Follow-up attempts are needed. Further information is requested.  Follow-up: This is a follow up-spontaneous report from a contactable other HCP (nurse). This other HCP (nurse) reported in response to HCP letter via follow-up letter:; Sender's Comments: Considering a plausible temporal relationship, a possible contributory role of suspect product BNT162B2 to the reported Insomnia, hair loss and Migraine cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
positive Ag 16May and sx 14May; positive Ag 16May and sx 14May; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 40-year-old male patient received BNT162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Lot number: EL3247), on 22Mar2021 as dose 2, single (Lot number: EL3247) and on 26Oct2021 as dose 3 (booster), single (Lot number: FF2589) at the age of 40 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 14May2022, outcome "unknown" and all described as "positive Ag 16May and sx 14May". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16May2022) Positive. It was unknown if therapeutic measures were taken as a result of vaccination failure, covid-19.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the available information, there is a reasonable possibility of a causal relationship between the suspect vaccine BNT162B2 (COMIRNATY) and reported events Vaccination failure and COVID-19 which cannot be fully assessed/excluded. The case will be reassessed if additional information becomes available.
My feet started itching and started getting hives on my feet,legs,thights,arm and shoulders .They would get bigger and the itch would not stop. It started the day( 2/4/22 )i got my third shot and i still have them.
moderate to severe redness, pain at injection site; moderate to severe redness, pain at injection site; Swelling; Decreased range of motion.; This is a spontaneous report from a contactable physician via a Pfizer sales representative. A female patient of an unspecified age (reported as age: 69, unit: unknown) received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13, lot number: X62332), via an unspecified route of administration on the left deltoid on 08May2019 at a single dose for immunization. The patient's medical history and concomitant medications were not reported. It was reported that 5 days after in office infection, patient contacted office for moderate to severe redness, pain at injection site on an unspecified date in 2019. Swelling, decreased range of motion were also reported on an unspecified date in 2019. The patient was seen in the office on 13May2019 and was prescribed Keflex (unspecified for which event). No other 5 injections were given. The outcome of the events was unknown.
Two hours post vax, the pt developed a fever of 104, severe leg pain, and vomiting. Her symptoms resolved on 8/9/99.
Client was given Tdap and HPV9 vaccines in R deltoid, followed by MCV4 IM in L deltoid. Immediately following third vaccine, client's eyes rolled back in head and she became unresponsive. This was followed by extremity rigidity, both arms and some visible tremors. Within 2-3 minutes, client relaxed and eyes began to focus. She appeared disoriented and did not respond verbally, but looked at provider when her name was called. She gradually became more alert and oriented, able to give her name and age. She was evaluated by physician on site. BP 123/79, P78, R18. Client was given juice and crackers, as she had not eaten since breakfast. At the onset of the event, 911 was called. The EMT squad arrived and also evaluated vital signs and level of consciousness. No visible injuries were sustained. The mother declined transport to the hospital. On further questioning with the mother, it was determined that the client had fainted previously when she had gone long periods without eating. The client continued to be observed for 20 -30 minutes and then left ambulatory with mother.
I had a sore shoulder for about three days after receiving the vaccine. I started with a sore throat, and I felt achy while out of town for two days. I tested positive for COVID-19 on 06/08/2022. I went to an emergency room because I had a terrible sore throat. They had to spray my throat with something so I could swallow. I was giving the prescription for PAXLOVID. I had a lot of congestion, and I went back to the doctor. In December 2022, I was diagnosed with bronchitis. Both illnesses occurred after I visited with my daughter. As of today, I have a very weak voice.
Severe right arm numbness and tingling in right hand and pain into my forearm, has not resolved since the day I got the vaccine. Started the second I received the vaccine. It has caused me extreme emotional stress and effects my ability to do my job as a paramedic.
Large erythematous, mildly warm, patch on left upper lateral arm - measures 10 cm wide  x 16 cm long.
Developed screaming incessantly & had large indurated area of inject site. Given a shot for pain.  Advised to get DT in future.
bad rash, that is extremely itchy, red and hot on the site of injection; bad rash, that is extremely itchy, red and hot on the site of injection; bad rash, that is extremely itchy, red and hot on the site of injection; bad rash, that is extremely itchy, red and hot on the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (bad rash, that is extremely itchy, red and hot on the site of injection), INJECTION SITE PRURITUS (bad rash, that is extremely itchy, red and hot on the site of injection), INJECTION SITE RASH (bad rash, that is extremely itchy, red and hot on the site of injection) and INJECTION SITE ERYTHEMA (bad rash, that is extremely itchy, red and hot on the site of injection) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer. Concurrent medical conditions included Blood pressure. Concomitant products included LETROZOLE for Breast cancer, high blood pressure medication, ATORVASTATIN and ALIROCUMAB (PRALUENT) for an unknown indication.  On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE WARMTH (bad rash, that is extremely itchy, red and hot on the site of injection), INJECTION SITE PRURITUS (bad rash, that is extremely itchy, red and hot on the site of injection), INJECTION SITE RASH (bad rash, that is extremely itchy, red and hot on the site of injection) and INJECTION SITE ERYTHEMA (bad rash, that is extremely itchy, red and hot on the site of injection). The patient was treated with AVENA SATIVA FLUID EXTRACT (AVEENO) (topical) for Itching, at a dose of Cream. At the time of the report, INJECTION SITE WARMTH (bad rash, that is extremely itchy, red and hot on the site of injection), INJECTION SITE PRURITUS (bad rash, that is extremely itchy, red and hot on the site of injection), INJECTION SITE RASH (bad rash, that is extremely itchy, red and hot on the site of injection) and INJECTION SITE ERYTHEMA (bad rash, that is extremely itchy, red and hot on the site of injection) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
moderately itchy rash on chest and burning ears about 1 hour after the vaccine. progressed to mild diffuse itching which slowly subsided over the few hours; moderately itchy rash on chest and burning ears about 1 hour after the vaccine. progressed to mild diffuse itching which slowly subsided over the few hours; This is a spontaneous report from a contactable physician (patient). A 36-year-old female patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: EK9231) on 05Jan2021 06:15 PM, Intramuscularly at single dose (vaccine location: Left arm) (first dose) for COVID-19 immunization. Medical history included cellulitis of lips due to use of 5 fu (stopped 1 week prior) for actinic keratosis. Concomitant medications included sulfamethoxazole, trimethoprim (BACTRIM) from 05Jan2021; amoxicillin, clavulanic acid (AUGMENTIN) from 05Jan2021; bupropion hydrochloride (WELLBUTRIN); escitalopram oxalate (LEXAPRO); magnesium; famotidine (PEPCID); ergocalciferol (VIT D); ascorbic acid (VIT C). There were no Known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient experienced moderately itchy rash on chest and burning ears about 1 hour after the vaccine on 05Jan2021 07:30 PM, progressed to mild diffuse itching which slowly subsided over the few hours. Patient did not receive any treatment. The outcome of the events was recovering. This case was assessed non-serious by reporter. The events did not result in Death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.
Cramp/pain of B/L back of thigh and B/L antecubital fossa, headache & cough. Ambulation ok. No sore throat. No evidence of toxic symptom. No evidence of stiff neck. Fever (T. 100 degrees F) x 2 days, recovered with TYLENOL.
Widespread vesicles, DX chickenpox post vaccination, TX  Atarax. Vaccine given 2/11/1998, Adverse event onset 2/20/2006.
Week1 - fever, muscle pain, jaw pain, joint pain, fatigue, brain fog, malaise, chest pain, trouble breathing, trouble moving/walking stairs tissue / joint swelling  Weeks 2 -6 (currently to date) - muscle pain,  malaise, fatigue, chest pain, trouble moving/walking up stairs, tissue/joint swelling, vision changes/blurriness
Patient called me and told me that she got Shingrix shot from our pharmacy and she got the reaction of it. Her skin became sore, blouchy and painful to touch on the spot where she got the shot. I told her that she has to see the doctor for that. I don't know if she went to see the doctor or not yet.
8 x 6cm area of redness appearing this AM.  Cold compress, Zyrtec OR 1.0 tp.
Hives, coughing 1 hr after injection. Seen in after hour. Rx with systemic prednisone 30 mg qd x 2 and Atarax 25 mg qid. 2/26/10 visit - fading uticaria / macular rash leg.
Initial misuse report received from a healthcare professional on 13 February 2013. A dose of MENACTRA that had expired on 08 February (year not specified) was administered on 11 February (year not specified). No information was provided regarding the patient. No adverse event was reported. List of documents held by sender: none.
80-year-old male presents emergency department by EMS in no acute distress with stable vital signs. He is not hypoxic.  5 days ago he was seen with his wife in the emergency department and both diagnosed with Covid. She was hypoxic and he was not so she was admitted and he went home. He has been on steroids.  He called EMS tonight because he still did not feel good, he was weak and he vomited twice.  No chest pain.  No fever.  His blood sugar was over 400.  He states he was a borderline diabetic.  His blood sugar in the hospital 5 days ago was 249.  He does not take any diabetic medication including orals or insulin. Associated Symptoms: cough, fatigue, nausea, URI symptoms, vomiting, weakness
Pericarditis with Pericardial Effusion. Symptoms: Chest pain, brain fog, shortness of breath, Palpitations, irregular spikes in heart rate, fatigue, weak limbs, dizziness, pins and needles sensation going down the back of head and nape of my neck and fingertips, migraine headache, elevated and abnormal  D Dimer. Still on bed rest and out of work on leave.  I was hospitalized and monitored overnight. I was screened for blood clots since D Dimer  was (and still is a abnormal) Doctors are dismissive and I went to 4 cardiologists  to finally get a diagnosis and medication (colchicine and ibuprofen) for 3 months.
This is a spontaneous reported by a contactable Physician. This Pfizer sales representative reported on behalf of a physician regarding a female patient who received PREVNAR 13, dose unknown, at an unknown time on an unknown anatomical site on an unknown date. Relevant medical history was unknown. Relevant concomitant medications were not reported. Vaccines given on the same day were not specified. Vaccines taken within the last four weeks were unknown. On an unknown date while on an unknown dose of PREVNAR 13 she experienced high fever. Relevant lab data was unknown. At the time of report clinical outcome of the event was unknown. Follow-up (23FEB2011): Follow-up attempts completed. No further information is needed.
Sore arm for 4-3 days, worse than usual after a vaccine; no redness, but muscle soreness at and near site.  Headache. Fairly sleepless night following the shot, mainly due to arm soreness and headache, but also feverish, cold extremities. Skin sensitive to touch for a day or two, similar to occasional sensitivity from my mild fybromyalgia; difference in this case was that the sensitivity was all over my body, rather than confined to a specific area.
Lymph node under LUE, axillary lymph node, swollen to size of baseball on 09/11/21. Has remained swollen through today's date 09/21/21. Painful and bruised
Atrial fibrillation, Metoprolol, Xarelto,  Symptoms lasted about 18 hours
Lumbar pain/back pain/Acute right-sided low back pain; arthralgias/Hip pain; tenderness; bony tenderness; fatigue; neck pain; neck stiffness; myalgias; foot pain/Pain in left foot; This case was reported by a lawyer and described the occurrence of lumbar pain in a patient who received Herpes zoster (Shingrix) for drug use for unknown indication.   On an unknown date, the patient received Shingrix (unknown). On an unknown date, an unknown time after receiving Shingrix, the patient experienced lumbar pain. The action taken with Shingrix was unknown. On an unknown date, the outcome of the lumbar pain was unknown.   It was unknown if the reporter considered the lumbar pain to be related to Shingrix.  The initial information was received on 10 December 2020 via medical record (case is now medically confirmed). The patients current condition included environmental allergies. On 24 July 2019 the patient prescribed with Shingrix 50MCG/0.5ML. As per report dated on 15 August 2019, patient had 2/2 shingrix 7/24. On 30 June 2016 reported that, patient had back pain and arthralgias and She had tenderness (anterior/posterior shoulder) and bony tenderness. On 02 November 2016 reported that, patient had myalgias. As per medical record dated on 21 Nov 2017, The patient assessed for Acute right-sided low back pain. Medical record dated on 13- Feb 2018, patient had neck pain and neck stiffness, foot pain.
This spontaneous report as received from a pharmacist refers to an unspecified number of patient of unknown age and gender. On an unknown dates the patients were vaccinated with ZOSTAVAX (doses and lot numbers not reported). On an unknown dates the patients experienced swelling reaction described as "as big as a baseball" at the injection site. The outcome of injection site swelling and relatedness between event and vaccination were not reported. Additional information has been requested.
Information has been received from a 50 year old male company representative with no pertinent medical history who on 12/02/03 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy included interferon (unspecified) and "ribovioren".  On 12/03/03 the pt experienced soreness in his tricep muscle, a fever below 102, a headache and muscle aches throughout his body. Medical attention has not been sought and no lab tests were performed. No product quality complaint was involved. Additional information has been requested.
Grandmother reported that mother monitored child's temperature throughout the day.  He was afebrile up to 5 hours p vaccinations. At about 1600, mother reported his temperature was 101 F. At approximately 1630 on 11/12/2013, the same day of the patient's visit to the clinic for vaccinations, he was playing with a family pet and fell to the ground with a seizure.  Patient was brought to a local hospital.  Medical records indicate he suffered a febrile seizure.  Patient was given OTC fever-reducing medications and observed for approximately two hours, then released.
I woke up at 1am freezing w/Headache. All my joints are aching. And my nose is plugged. Pain scale for headache was about a 4-5. so it?s like I have a normal cold. The injection site hurts to touch. A teeny bit swollen.
Denies unusual local or systemic reaction between 3/19 and 3/30/03. On 3/31/03, patient had new onset seizure-like activity lasting approximately 3 minutes. Witness described patient becoming unresponsive, with legs extended out and stiffened, and arms flexed, upright and shaking. Eyes rolled straight back in head, not deviated. No neck deviation. On 4/17/03 (10 days after 2nd Anthrax), patient had 2nd similar episode of witnessed seizure like activity, only L) leg was bent and both arms were flexed with fists above head, shaking. Pt. evaluated by Neuro on 4/18/03 - Impression: Seizure, likely GTC/recent vaccination may play a role. No suggestion of encephalitis. MRI and EEG ordered (pending). Started on Carbamazepine 200mg BID and given 6 month profile limiting duties. Follow up: Pt has not received additional anthrax vaccines. She has experienced two additional seizures episodes since her last VAERS was reported; both episodes had precipitating factors.  Current problem list: Seizure disorder, left shoulder pain.
Received injection Wednesday at approximately 1130 AM - 12+ hours after injection fever 100.4, body aches, headache, fatigue.  By Sunday I had a cough, headaches continued. By Wednesday I had been coughing so bad I was lightheaded and wheezing.  Got tested Thursday for covid and influenza.  Found Thursday night those were negative.  Treatment OTC included vitamin C, ibuprofen, Mucinex, Sudafed, Nyquil. Sunday I was seen in urgent care for chest x-ray to check for pneumonia, was given a Duoneb nebulizer treatment and prescribed a 5 day course of prednisone as well as an albuterol inhaler.
Participant c/o dizziness and feeling "tingly all over".  States has had numerous allergic reactions in the past.  B/P 180/98, pulse 81, O2 sat 96%  EMS arrived and assessed participant;  B/P 188/ 118.  Continued to complain of ongoing symptoms, agreed to go to E.D. to be further assessed.
An hour after shots he was very tired and pale looking, he just wanted held and laid around. I gave him Tylenol, put him to bed at 7:15. He started seizure at 11:00 and lasted about 5 minutes. Temp was 100.8 degrees and ran a fever for 9 days afterwards between 100 to 102 degrees.
Initially started to get more irritable and clingy, then started shivering, became mottled, temp only up to 100, gave Tylenol, warm bath, mom brought her back to the office by which time she was fine.
Woke up and the room was spinning, carefully walked to the bathroom for drink of water, had to sit and wait for the room to stop spinning. When I tried to lay down it started spinning again and I found I could not focus on single spot. At 9am The spinning stopped but I feel very weak.
This spontaneous prospective pregnancy report was received from a physician via a company representative referring to approximately 14 year old female patient. Pertinent medical history and concurrent conditions were unspecified. On 27-MAY-2008 the patient received the first dose of GARDASIL, on 17-JUL-2008 received the second dose and on 20-OCT-2010 received dose 3 of GARDASIL. No other concomitant therapies reported. The company representative was told by the physician that he had a patient who called the office upset because she was pregnant (date unspecified) and had been informed that she tested positive for HPV. The LMP and EDD was not known. The patient had not sought medical attention. The pregnancy outcome was pending. The outcome of the events was unknown. The causality of the events was unspecified. Additional information has been requested.
Information has been received from a nurse practitioner (NP) and registered nurse (RN) concerning a 32-year-old female who with no allergies who on 21-JUL-2005 was vaccinated SC in the left upper arm with a first dose of varicella virus vaccine live (Oka/Merck) (Lot #649740/0221R). Concomitant therapy included albuterol. There was no illness at the time of vaccination. The NP reported that on 11-AUG-2005, the patient developed a rash characterized by about 50 lesions on her trunk and extremities. On 15-AUG-2005, the patient also developed a low fever and runny nose. Unspecified medical attention was sought, but no laboratory/diagnostic tests were performed. On 19-Aug-2005, the patient's vesicular rash resolved. At the time of this report, the outcome of the patient's low fever and runny nose was unknown. No other information is available.
I had a runny nose & a sore throat & then I started having chest coughs & then I had to go to ER my muscles were having spasms & i had to go to ER twice because I tested positive for Covid-19
Fever, headache, neck pain posterior, anthralgias, chills photophobia, dizzy.